By Rahul Koul
“ There is a growing trend towards outsourcing clinical trials to India ”
In an exclusive interview , Dr Mahesh Bhalgat , Managing Director & Group CEO , Veeda Clinical Research Limited shares his vision for the company , latest developments , long-term growth , industry trends and future outlook .
By Rahul Koul
It has been close to six months since your stint began at Veeda Clinical Research . How has been the journey so far and your short as well as long term objectives for the company ?
Till date , it has been an exciting journey for me at Veeda . The acquisitions have resulted in substantial increase in number of clinical trial sites globally , which are now part of Veeda ’ s network . Veeda is now a truly global CRO with multinational and multi-locational delivery centers across the globe where we have added capabilities in the late-stage clinical trials and are now offering or participating in global clinical trials .
We continue to work on restructuring our business operations across the globe , which primarily focus on enhancing operational efficiency and aligning different businesses to work cohesively and achieve results that are in line with expectations of our clients . The restructuring of businesses will enable Veeda to adapt to market dynamics , customer demands , and emerging trends , ensuring its longterm competitiveness and growth in a rapidly changing business environment .
Veeda is now organized under four strategic business units . Firstly , Clinical Trials businesl comprises operations in Europe ( originally Health
BioTech
BIOVOICENEWS . COM 23